AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2012
Aug 3, 2012
30291_dirs_2012-08-03_17919391-dac6-4853-85ee-d2ec91446932.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2012-08-02
Reporting Person: ALEXANDER SUSAN H (EVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-02 | Common Stock | S | 1165 | $142.99 | Disposed | 9020 | Direct |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6